EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Continuous subcutaneous foscarbidopa/foslevodopa infusion as a therapeutic option in spinocerebellar ataxia type 8 presenting with early-onset parkinsonism

Francesco Onorati, Lorenzo Malfer, Lauren M Jackson, Zhiyv Niu, Owen A Ross, Rodolfo Savica

Clinical Parkinsonism & Related Disorders · 2026 · 15 · 100496

DOI: 10.1016/j.prdoa.2026.100496 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Parkinsonism & Related Disorders, 2026. Verfasst von Francesco Onorati und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Mayo Clinic, Rochester, MN, USA. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In response to a case report on a patient with spinocerebellar ataxia type 8, presenting with early-onset parkinsonism and treated with deep brain stimulation, we report an analogous case, who responded optimally to continuous subcutaneous foscarbidopa/foslevodopa infusion.

Schlagwörter

Stichwörter der Autor:innen

Early-onset parkinsonismFoscarbidopa/foslevodopa continuous subcutaneous infusionSCA8

Autor:innen und Institutionen

  • Department of Neurology, Mayo Clinic, Rochester, MN, USA.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Department of Clinical Genomics, Mayo Clinic, Rochester, MN, USA.

Zitieren

APA

Onorati, F., Malfer, L., Jackson, L. M., Niu, Z., Ross, O. A., & Savica, R. (2026). Continuous subcutaneous foscarbidopa/foslevodopa infusion as a therapeutic option in spinocerebellar ataxia type 8 presenting with early-onset parkinsonism. Clinical Parkinsonism & Related Disorders, 15, 100496. https://doi.org/10.1016/j.prdoa.2026.100496

Vancouver

Onorati F, Malfer L, Jackson LM, Niu Z, Ross OA, Savica R. Continuous subcutaneous foscarbidopa/foslevodopa infusion as a therapeutic option in spinocerebellar ataxia type 8 presenting with early-onset parkinsonism. Clinical Parkinsonism & Related Disorders. 2026;15:100496. doi:10.1016/j.prdoa.2026.100496

BibTeX
@article{Onorati2026,
  author = {Onorati, Francesco and Malfer, Lorenzo and Jackson, Lauren M and Niu, Zhiyv and Ross, Owen A and Savica, Rodolfo},
  title = {Continuous subcutaneous foscarbidopa/foslevodopa infusion as a therapeutic option in spinocerebellar ataxia type 8 presenting with early-onset parkinsonism},
  journal = {Clinical Parkinsonism & Related Disorders},
  year = {2026},
  volume = {15},
  pages = {100496},
  doi = {10.1016/j.prdoa.2026.100496}
}
Kostenlos starten →